Implication of Hepsin from Primary Tumor in the Prognosis of Colorectal Cancer Patients

por Zaragoza-Huesca, David, Nieto-Olivares, Andrés, García-Molina, Francisco, Ricote, Guillermo, Montenegro, Sofía, Sánchez-Cánovas, Manuel, Garrido-Rodríguez, Pedro, Peñas-Martínez, Julia, Vicente, Vicente, Martínez, Francisco, Lozano, María Luisa, Carmona-Bayonas, Alberto, Martínez-Martínez, Irene
Publicado 2022

Venetoclax is a potent hepsin inhibitor that reduces the metastatic and prothrombotic phenotypes of hepsin-expressing colorectal cancer cells

por Rodenas, Maria Carmen, Peñas-Martínez, Julia, Pardo-Sánchez, Irene, Zaragoza-Huesca, David, Ortega-Sabater, Carmen, Peña-García, Jorge, Espín, Salvador, Ricote, Guillermo, Montenegro, Sofía, Ayala-De La Peña, Francisco, Luengo-Gil, Ginés, Nieto, Andrés, García-Molina, Francisco, Vicente, Vicente, Bernardi, Francesco, Lozano, María Luisa, Mulero, Victoriano, Pérez-Sánchez, Horacio, Carmona-Bayonas, Alberto, Martínez-Martínez, Irene
Publicado 2023